Evidence map›Paper›PMID 36679271›Full record

ArticlePolymers2023

Phytochemical Characterization and Efficacy of

Husam Qanash, Abdulrahman S Bazaid, Abdu Aldarhami, Bandar Alharbi, Majed N Almashjary, Mohannad S Hazzazi, Hashim R Felemban, Tarek M Abdelghany

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Natural Bioactive Compounds fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Gas Chromatography-Mass Spectrometry Analysis ofInternational journal of molecular sciences · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Exploring the Antibacterial Potential ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  19. Review
  20. Combating CariogenicMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Husam QanashDepartment of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, Hail 55476, Saudi Arabia.ORCID 0000-0002-3068-0313
Abdulrahman S BazaidDepartment of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, Hail 55476, Saudi Arabia.ORCID 0000-0002-5884-0278
Abdu AldarhamiDepartment of Medical Microbiology, Qunfudah Faculty of Medicine, Umm Al-Qura University, Al-Qunfudah 21961, Saudi Arabia.ORCID 0000-0002-0950-9263
Bandar AlharbiDepartment of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, Hail 55476, Saudi Arabia.ORCID 0000-0002-0385-7259
Majed N AlmashjaryDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 22254, Saudi Arabia.ORCID 0000-0002-6619-0287
Mohannad S HazzaziDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 22254, Saudi Arabia.ORCID 0000-0002-6321-8248
Hashim R FelembanDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 22254, Saudi Arabia.
Tarek M AbdelghanyBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo 71524, Egypt.
King Abdulaziz University · SAUniversity of Ha'il · SAAl-Azhar University · EGUmm al-Qura University · SA

Funding

Deputy for Research and Innovation, Ministry of Education through Initiative of Institutional Funding at University of Ha'il - Saudi Arabia IFP-22 052
6 · The paper itself

Abstract

Despite the advanced development in the field of drug discovery and design, fighting infectious and non-infectious diseases remains a major worldwide heath challenge due to the limited activity of currently used drugs. Nevertheless, in recent years, the approach of designing nanoparticles for therapeutic applications has gained more interest and promise for future use. Thus, the current study is focused on the evaluation of

Indexed as

anticancerantimicrobialArtemisiabio-efficacychitosan nanoparticles

Identifiers

PMID36679271
PMCPMC9865519
OpenAlexW4315781322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.